Nanobiotix (NBTX) Shares Outstanding (Weighted Average) (2018 - 2025)

Nanobiotix has reported Shares Outstanding (Weighted Average) over the past 8 years, most recently at $1.7 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) fell 100.0% year-over-year to $1.7 million; the TTM value through Dec 2025 reached $1.7 million, down 100.0%, while the annual FY2025 figure was $1.7 million, 100.0% down from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $1.7 million at Nanobiotix, up from $124.52 in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $50.5 billion in Q4 2024 and troughed at $124.52 in Q2 2025.
  • A 5-year average of $9.0 billion and a median of $845625.5 in 2021 define the central range for Shares Outstanding (Weighted Average).
  • Biggest five-year swings in Shares Outstanding (Weighted Average): surged 111564.5% in 2023 and later tumbled 100.0% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $39.8 million in 2021, then fell by 10.69% to $35.6 million in 2022, then surged by 111564.5% to $39.7 billion in 2023, then rose by 27.12% to $50.5 billion in 2024, then tumbled by 100.0% to $1.7 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for NBTX at $1.7 million in Q4 2025, $124.52 in Q2 2025, and $50.5 billion in Q4 2024.